Women and #Election2024: Listening to Abigail Adams
With a handful of days before #Election2024 delivers final voters to polls in the U.S. on November 5th, Americans’ political stress is hitting fever pitches from all points on the U.S. political spectrum. Here is the sticker I am using in my journal today, November 1 2024, from Mental Health America. “Vote as if your mental health depends on it.” MHA has a portal devoted to 2024 Election Mental Health Resources, including a section with “mental health voter merch” to call out the phenomenon of political stress and support the efforts
Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update
In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.
Hims and Hers and Hearts – Cardiology Blurs Into DTC Retail Health
Statin therapy has been used for decades to lower cholesterol with the goal of reducing mortality and preventing cardiovascular problems such as heart attacks and strokes. Hims & Hers announced a new service offering for health consumers and clinicians concerned about heart health called Heart Health by Hims. This is Hims & Hers’ first foray into cardiovascular health, working in collaboration with the American College of Cardiology (ACC). ACC clinical guidelines will inform the Hims’ provider platform for the program. “Prevention is the ideal mechanism to decrease cardiovascular events and ensure optimal heart